Prognostic Value of Automated Bone Scan Index (aBSI) in Patients with mCRPC Undergoing Three vs. Six Cycles of 223Ra Therapy
Sign Up to like & getrecommendations! Published in 2025 at "Diagnostics"
DOI: 10.3390/diagnostics15162007
Abstract: Background/Objectives: In patients with metastatic castration-resistant prostate cancer (mCRPC) and osseous metastases only, 223Radium therapy represents a valuable therapeutic option. Bone scintigraphy (BS) is typically performed to assess metastasis load, with the BS-derived automated bone… read more here.
Keywords: therapy; absi; six cycles; three six ... See more keywords